Biliary Tract Tumors — MCQs
Treatment of choice for mucinous carcinoma of the gall bladder in the early stage is -
A 52-year-old recent immigrant from Vietnam presents with abdominal swelling, weight loss, and upper abdominal pain of three weeks' duration. His past medical history includes malaria and infection with Clonorchis sinensis. On palpation, the liver is hard. An abdominal CT scan reveals a hypo-attenuated mass with lobulated margins in the liver, and a biopsy shows well-differentiated neoplastic glands embedded in a dense fibrous stroma. What is the most likely diagnosis?
A 50-year-old alcoholic patient presents with a history of waxing and waning jaundice for the past 2 months. His CT examination reveals dilatation of the common bile duct and pancreatic duct. What is the most probable diagnosis in the patient?
Which of the following is not a risk factor for cholangiocarcinoma?
A 60-year-old chronic smoker presented with progressive jaundice, pruritus, and clay-colored stools for 2 months, with a history of waxing and waning of jaundice. A CT scan revealed dilated main pancreatic duct and common bile duct. What is the likely diagnosis?
The following procedure is performed for the management of?
A patient presents with painless jaundice and a palpable gallbladder. What is the most likely diagnosis?
A 52-year-old woman presents with jaundice, pale stools, and a palpable gallbladder. MRCP shows a dilated bile duct but no stones. What is the next best step?
Treatment of a symptomatic simple cyst of the liver is:
In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?
Biliary Tract Tumors Indian Medical PG Practice Questions and MCQs
Question 1: Treatment of choice for mucinous carcinoma of the gall bladder in the early stage is -
- A. Simple cholecystectomy (Correct Answer)
- B. Extended cholecystectomy
- C. Cholecystectomy with wedge resection of liver
- D. Chemotherapy only
Explanation: ***Simple cholecystectomy*** - For **early-stage (T1a) mucinous carcinoma of the gallbladder**, **simple cholecystectomy** is the treatment of choice - T1a disease (tumor confined to mucosa) has an excellent prognosis with **5-year survival >90%** after simple cholecystectomy alone - Extended resection offers **no survival benefit** for T1a disease and increases surgical morbidity - If incidentally discovered post-cholecystectomy with negative margins, no further surgery is needed *Extended cholecystectomy* - **Extended cholecystectomy** (cholecystectomy + liver segments IVb/V resection + portal lymphadenectomy) is indicated for **T2 or higher stage** disease (tumor invading muscularis propria or beyond) - This is **not** the treatment for early-stage disease as it increases morbidity without survival benefit - Reserved for more advanced tumors with deeper invasion *Cholecystectomy with wedge resection of liver* - This describes a component of extended cholecystectomy and is similarly indicated for **T2+ disease**, not early-stage - Wedge resection aims to achieve negative margins when tumor extends beyond the gallbladder wall - Not appropriate for early-stage mucinous carcinoma confined to mucosa *Chemotherapy only* - **Chemotherapy alone** is not curative for early-stage gallbladder carcinoma - Surgery remains the primary curative treatment for resectable disease - Chemotherapy is reserved for advanced, metastatic, or unresectable disease as palliative treatment
Question 2: A 52-year-old recent immigrant from Vietnam presents with abdominal swelling, weight loss, and upper abdominal pain of three weeks' duration. His past medical history includes malaria and infection with Clonorchis sinensis. On palpation, the liver is hard. An abdominal CT scan reveals a hypo-attenuated mass with lobulated margins in the liver, and a biopsy shows well-differentiated neoplastic glands embedded in a dense fibrous stroma. What is the most likely diagnosis?
- A. Cholangiocarcinoma (Correct Answer)
- B. Gallbladder carcinoma
- C. Angiosarcoma
- D. Hepatic adenoma
Explanation: ***Cholangiocarcinoma*** - The history of **Clonorchis sinensis** infection is a significant risk factor for the development of cholangiocarcinoma, a malignancy of the bile ducts [1]. - The presentation of a **hypo-attenuated mass** with well-differentiated glands in the biopsy is characteristic of cholangiocarcinoma, especially given the patient's background. [1] *Carcinoma of the gallbladder* - Typically presents with mass lesions, but would more likely show **gallbladder wall thickening** rather than a hypo-attenuated mass in the liver. - Associated with **gallstones** and chronic inflammation, which are not indicated in this patient's history. *Hemangiosarcoma* - More commonly found in the spleen or heart; liver involvement is rare. - Biopsy would show **vascular spaces** rather than well-differentiated neoplastic glands, making it less likely in this case. *Hepatocellular carcinoma* - Generally develops in patients with **chronic liver disease** and shows a more **vascular** appearance on imaging [2]. - The biopsy findings of well-differentiated glands and the absence of cirrhotic liver history point away from hepatocellular carcinoma.
Question 3: A 50-year-old alcoholic patient presents with a history of waxing and waning jaundice for the past 2 months. His CT examination reveals dilatation of the common bile duct and pancreatic duct. What is the most probable diagnosis in the patient?
- A. Common bile duct stone
- B. Head of the pancreas carcinoma
- C. Cholangiocarcinoma
- D. Periampullary carcinoma (Correct Answer)
Explanation: ***Periampullary carcinoma*** - **Waxing and waning jaundice** is the **most characteristic feature** of periampullary tumors, as the tumor may intermittently obstruct and then temporarily release the **ampulla of Vater** (due to tumor friability, inflammation, or necrosis allowing temporary drainage). - The combination of **dilated common bile duct (CBD)** and **pancreatic duct (double duct sign)** indicates obstruction at the level of the ampulla. - The **intermittent nature of jaundice** is the key distinguishing feature that makes periampullary carcinoma more likely than pancreatic head carcinoma in this case. *Head of the pancreas carcinoma* - A **carcinoma of the head of the pancreas** also causes the **double duct sign** and can present with obstructive jaundice. - However, pancreatic head tumors typically cause **progressive, persistent, and painless jaundice** rather than waxing and waning jaundice, as the tumor causes constant external compression of both ducts. - This is a close differential, but the **fluctuating jaundice** favors a periampullary lesion. *Common bile duct stone* - While a **CBD stone** can cause waxing and waning jaundice due to intermittent obstruction (stone moving in and out of ampulla), it is **less likely to cause isolated dilatation of both the pancreatic duct and CBD** (double duct sign). - Stones typically cause **biliary colic, cholangitis, or pancreatitis** rather than isolated double duct dilatation. - The **double duct sign** without inflammatory features points more strongly to malignancy at the ampulla. *Cholangiocarcinoma* - **Cholangiocarcinoma** can cause biliary obstruction and jaundice, but it typically arises within the bile ducts themselves (intrahepatic or hilar). - **Distal cholangiocarcinoma** near the ampulla can mimic periampullary carcinoma, but it is less common for it to cause the degree of **pancreatic duct dilatation** seen in the double duct sign. - Cholangiocarcinoma usually causes **progressive rather than fluctuating jaundice**.
Question 4: Which of the following is not a risk factor for cholangiocarcinoma?
- A. Thorotrast
- B. Radon
- C. Dioxin
- D. Aflatoxin (Correct Answer)
Explanation: ***Aflatoxin*** - **Aflatoxin** is a potent **hepatocarcinogen** produced by *Aspergillus* species that is specifically and strongly linked to **hepatocellular carcinoma (HCC)** [1], NOT cholangiocarcinoma. - This is the **most clearly unrelated** risk factor to cholangiocarcinoma among the options, as its carcinogenic mechanism targets hepatocytes specifically [1], [2]. - It contaminates crops in warm, humid regions and is a well-established cause of liver cancer in endemic areas [1]. *Thorotrast* - **Thorotrast** (thorium dioxide) was a radioactive contrast agent used until the 1950s that **IS a known risk factor** for cholangiocarcinoma. - Due to prolonged retention in the liver and biliary system, it significantly increases the risk of both **cholangiocarcinoma** and **hepatic angiosarcoma** [3]. - Its use was discontinued precisely because of its strong carcinogenic potential. *Radon* - **Radon** is a naturally occurring radioactive gas that is primarily and overwhelmingly associated with **lung cancer** from inhalation exposure. - While a potent carcinogen, it has **no established epidemiological link** to cholangiocarcinoma due to its route of exposure and target organ. *Dioxin* - **Dioxins** are environmental pollutants with documented carcinogenic effects. - While some studies have explored potential links to various cancers, dioxin is **not recognized as an established risk factor** for cholangiocarcinoma in major medical references. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 876-877. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 331-332. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 216-217.
Question 5: A 60-year-old chronic smoker presented with progressive jaundice, pruritus, and clay-colored stools for 2 months, with a history of waxing and waning of jaundice. A CT scan revealed dilated main pancreatic duct and common bile duct. What is the likely diagnosis?
- A. Chronic pancreatitis
- B. Periampullary carcinoma (Correct Answer)
- C. Carcinoma head of pancreas
- D. Hilar cholangiocarcinoma
Explanation: ***Periampullary carcinoma*** - The key feature here is **waxing and waning jaundice**, which is a classic presentation of periampullary carcinoma due to the tumor's location at the ampulla of Vater. - **Mechanism**: The friable tumor tissue can undergo necrosis and sloughing, temporarily relieving the obstruction and causing fluctuating jaundice. - Both **dilated common bile duct and pancreatic duct (double duct sign)** are seen because the tumor involves the ampulla where both ducts converge. - **Chronic smoker** is a risk factor for pancreaticobiliary malignancies. - **Painless obstructive jaundice** with pruritus and clay-colored stools indicates extrahepatic biliary obstruction. *Carcinoma head of pancreas* - While this can also cause the **double duct sign** and obstructive jaundice, it typically presents with **steadily progressive jaundice** rather than waxing and waning. - Pancreatic head tumors cause persistent compression of the CBD, leading to continuous obstruction. - The fluctuating pattern is NOT characteristic of pancreatic head carcinoma. *Chronic pancreatitis* - Can cause dilated ducts and obstructive jaundice due to **fibrotic strictures**, but typically presents with **recurrent abdominal pain** and a history of repeated inflammatory episodes. - Pain is a predominant feature, which is absent in this case. - The clinical picture of painless progressive jaundice favors malignancy over inflammatory disease. *Hilar cholangiocarcinoma* - **Klatskin tumor** affects the confluence of hepatic ducts, causing **intrahepatic bile duct dilation** with normal or minimally dilated distal CBD. - **Pancreatic duct dilation would NOT occur** with hilar cholangiocarcinoma. - The presence of both dilated CBD and pancreatic duct rules this out.
Question 6: The following procedure is performed for the management of?
- A. Gallbladder carcinoma
- B. Distal cholangiocarcinoma (Correct Answer)
- C. Chronic calcific pancreatitis
- D. Advanced gastric carcinoma
Explanation: ***Distal cholangiocarcinoma*** - The image shows a **Pylorus-preserving Whipple procedure (PPPD)**, which involves resection of the pancreatic head, duodenum, gallbladder, and part of the common bile duct, followed by reconstruction. - This procedure is primarily performed for malignancies of the **pancreatic head**, **distal bile duct (cholangiocarcinoma)**, and **ampulla of Vater**, as they often cause obstructive jaundice and are resectable. *Gallbladder carcinoma* - While gallbladder carcinoma can involve the bile ducts, this specific reconstruction (PPPD) is more commonly associated with tumors of the pancreatic head or distal bile duct rather than the gallbladder itself, which might be managed with a **cholecystectomy** and possibly **liver resection**. - The type of resection and reconstruction varies significantly based on the extent and location of gallbladder cancer. *Chronic calcific pancreatitis* - Surgical management for chronic pancreatitis, especially with calcifications, typically involves drainage procedures (e.g., **Puestow procedure** due to dilated pancreatic duct or **Frey procedure**) or resection of the pancreatic head (e.g., **Beger procedure**). - While some resections of the pancreatic head are performed for chronic pancreatitis, the depicted procedure is specifically designed for malignancies of the pancreatic head region, not primarily for the sequelae of chronic calcific pancreatitis unless associated with a mass suspicious for malignancy. *Advanced gastric carcinoma* - Advanced gastric carcinoma is typically managed by **gastrectomy** (partial or total) with lymphadenectomy, not a Whipple procedure. - The image clearly shows an **intact pylorus** and the stomach mostly preserved, which is inconsistent with advanced gastric carcinoma requiring major gastric resection.
Question 7: A patient presents with painless jaundice and a palpable gallbladder. What is the most likely diagnosis?
- A. Cholecystitis
- B. PSC
- C. Pancreatic cancer (Correct Answer)
- D. Hepatitis
Explanation: ***Pancreatic cancer*** - The combination of **painless jaundice** and a **palpable gallbladder** (Courvoisier's sign) is highly suggestive of an obstruction of the common bile duct, most commonly due to pancreatic head cancer. - The tumor in the head of the pancreas compresses the common bile duct, leading to bile back-up and distension of the gallbladder, which is often palpable and non-tender due to the slow, progressive nature of the obstruction. *Cholecystitis* - Cholecystitis typically presents with **painful right upper quadrant abdominal pain**, fever, and nausea, usually due to gallstone obstruction of the cystic duct. - While jaundice can occur if a stone migrates to the common bile duct, the prominent feature of **pain** and the common absence of a palpable, non-tender gallbladder differentiate it. *PSC* - **Primary sclerosing cholangitis (PSC)** is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis of the bile ducts, which can cause jaundice. - PSC typically doesn't present with a **palpable gallbladder**; it's often associated with inflammatory bowel disease and can lead to cholangitis or cholangiocarcinoma. *Hepatitis* - **Hepatitis** causes jaundice due to hepatocyte dysfunction and inflammation, leading to impaired bilirubin conjugation and excretion. - It usually presents with symptoms like fatigue, nausea, and dark urine, but it does **not typically cause a palpable gallbladder** because it's a hepatocellular rather than an obstructive process.
Question 8: A 52-year-old woman presents with jaundice, pale stools, and a palpable gallbladder. MRCP shows a dilated bile duct but no stones. What is the next best step?
- A. Liver biopsy
- B. ERCP with biopsy
- C. Cholecystectomy
- D. CT scan of the abdomen (Correct Answer)
Explanation: ***CT scan of the abdomen*** - The combination of **jaundice**, **pale stools**, a **palpable gallbladder**, and a **dilated bile duct without stones** (Courvoisier's sign) strongly suggests an obstructing mass in the head of the pancreas or distal common bile duct. - A **CT scan of the abdomen** is the initial investigation of choice to visualize and stage potential pancreatic or biliary malignancies. *Liver biopsy* - A liver biopsy is typically performed to evaluate **parenchymal liver disease** or unexplained liver enzyme elevations, not primarily for obstructive jaundice. - It would not identify the cause of the obstruction in the bile duct. *ERCP with biopsy* - **ERCP (Endoscopic Retrograde Cholangiopancreatography)** is both diagnostic and therapeutic, often used to retrieve stones or place stents. - While it could provide a biopsy, it is a more invasive procedure and usually reserved after less invasive imaging like CT has localized the likely obstruction. *Cholecystectomy* - **Cholecystectomy (gallbladder removal)** is indicated for symptomatic gallstones or gallbladder polyps. - In this case, the problem is not within the gallbladder itself, but rather an obstruction of the common bile duct, indicated by the dilated bile duct and absence of stones.
Question 9: Treatment of a symptomatic simple cyst of the liver is:
- A. Percutaneous drainage
- B. Deroofing (Correct Answer)
- C. Aspiration
- D. Cystoenterostomy
Explanation: ***Deroofing*** - **Deroofing** (or fenestration) is the standard surgical treatment for symptomatic simple liver cysts. - This procedure involves **excising a portion of the cyst wall**, allowing permanent drainage into the peritoneal cavity and preventing recurrence. *Percutaneous drainage* - While sometimes used for initial diagnosis or symptom relief, **percutaneous drainage alone** of a simple cyst often leads to recurrence because the cyst wall remains intact and continues to produce fluid. - It is typically reserved for **patients who are not surgical candidates** or as a temporary measure. *Cystoenterostomy* - **Cystoenterostomy** involves creating a communication between the cyst and a loop of bowel (e.g., jejunum). - This procedure is generally reserved for **complex or large cysts** that are unresectable or in specific situations like pancreatic pseudocysts, and carries higher risks than deroofing for simple cysts. *Aspiration* - **Aspiration** is a temporary measure, similar to percutaneous drainage without sclerosing agents. - It almost always results in **recurrence** as the secretory lining of the cyst remains intact.
Question 10: In the Bismuth-Corlette classification, which type involves the hepatic duct confluence WITHOUT extension into secondary intrahepatic ducts?
- A. Type II (Correct Answer)
- B. Type IIIb
- C. Type I
- D. Type IV
- E. Type IIIa
- F. Type III
Explanation: ***Type II*** - This classification specifically describes **cholangiocarcinomas** located at the **hepatic duct confluence** without extension into secondary intrahepatic ducts. - **Type II tumors** involve the hepatic duct confluence but **do not extend** into the right or left secondary intrahepatic ducts. - This is the defining feature that distinguishes Type II from Type III variants. *Type I* - **Type I tumors** are located at least **2 cm distal to the hepatic duct bifurcation**. - This type involves the **common hepatic duct** and **spares the confluence** completely. - Does not meet the criteria of involving the confluence. *Type IIIa* - **Type IIIa tumors** involve the **hepatic duct confluence** with extension into the **right secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension into secondary ducts is the key differentiating feature. *Type IIIb* - **Type IIIb tumors** involve the **hepatic duct confluence** with extension into the **left secondary intrahepatic ducts**. - This represents extension **beyond** the confluence, unlike Type II. - The extension pattern differs from Type IIIa by involving the left rather than right system.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free